Management and outcome of retinoblastoma with vitreous seeds

Ophthalmology

Volumn 121, Issue 2, 2014, Pages 517-524

  Manjandavida, Fairooz P ^a   Honavar, Santosh G ^a,b   Reddy, Vijay Anand P ^a,b   Khanna, Rohit ^a  

^a L V PRASAD EYE INSTITUTE   (India)

^b Centre for Sight   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARBOPLATIN; CHILD; CHILD, PRESCHOOL; ETOPOSIDE; EYE ENUCLEATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFANT; INFUSIONS, INTRAVENOUS; MALE; NEOPLASM SEEDING; RADIOTHERAPY, ADJUVANT; RETINAL NEOPLASMS; RETINOBLASTOMA; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; VINCRISTINE; VISUAL ACUITY; VITREOUS BODY;

EID: 84895067281     PISSN: 01616420     EISSN: 15494713     Source Type: Journal    
DOI: 10.1016/j.ophtha.2013.09.011     Document Type: Conference Paper

References (40)

1. J.A. Shields, C.L. Shields, and V. Sivalingam Decreasing frequency of enucleation in patients with retinoblastoma Am J Ophthalmol 108 1989 185 188
2. C.L. Shields, S.G. Honavar, and A.T. Meadows et al. Chemoreduction in unilateral retinoblastoma Arch Ophthalmol 120 2002 1653 1658
3. J.A. Epstein, C.L. Shields, and J.A. Shields Trends in the management of retinoblastoma: evaluation of 1,196 consecutive eyes during 1974 to 2001 J Pediatr Ophthalmol Strabismus 40 2003 196 203
4. E.L. Berman, C.E. Donaldson, M. Giblin, and F.J. Martin Outcomes in retinoblastoma, 1974-2005: the Children's Hospital, Westmead Clin Experiment Ophthalmol 35 2007 5 12
5. E. Broaddus, A. Topham, and A.D. Singh Survival with retinoblastoma in the USA: 1975-2004 Br J Ophthalmol 93 2009 24 27
6. J.E. Kingston, J.L. Hungerford, S.A. Madreperla, and P.N. Plowman Results of combined chemotherapy and radiotherapy for advanced intraocular retinoblastoma Arch Ophthalmol 114 1996 1339 1343
7. A.L. Murphree, J.G. Villablanca, and W.F. Deegan III et al. Chemotherapy plus local treatment in the management of intraocular retinoblastoma Arch Ophthalmol 114 1996 1348 1356
8. C.L. Shields, P. DePotter, and B.P. Himmelstein et al. Chemoreduction in the initial management of intraocular retinoblastoma Arch Ophthalmol 114 1996 1330 1338
9. B.L. Gallie, A. Budning, and G. DeBoer et al. Chemotherapy with focal therapy can cure intraocular retinoblastoma without radiotherapy Arch Ophthalmol 114 1996 1321 1328
10. C.L. Shields, J.A. Shields, and M. Needle et al. Combined chemoreduction and adjuvant treatment for intraocular retinoblastoma Ophthalmology 104 1997 2101 2111
11. C.L. Shields, S.G. Honavar, and A.T. Meadows et al. Chemoreduction plus focal therapy for retinoblastoma: factors predictive of need for treatment with external beam radiotherapy or enucleation Am J Ophthalmol 133 2002 657 664
12. C.L. Shields, S.G. Honavar, and J.A. Shields et al. Factors predictive of recurrence of retinal tumor, vitreous seeds, and subretinal seeds following chemoreduction for retinoblastoma Arch Ophthalmol 120 2002 460 464
13. V.M. Cohen, J. Kingston, and J.L. Hungerford The success of primary chemotherapy for group D heritable retinoblastoma Br J Ophthalmol 93 2009 887 890
14. M.P. Chan, J.L. Hungerford, J.E. Kingston, and P.N. Plowman Salvage external beam radiotherapy after failed primary chemotherapy for bilateral retinoblastoma: rate of eye and vision preservation Br J Ophthalmol 93 2009 891 894
15. R.A. Kleinerman, M.A. Tucker, and R.E. Tarone et al. Risk of new cancers after radiotherapy in long-term survivors of retinoblastoma: an extended follow-up J Clin Oncol 23 2005 2272 2279
16. D.H. Abramson, I.J. Dunkel, and S.E. Brodie et al. A phase I/II study of direct intraarterial (ophthalmic artery) chemotherapy with melphalan for intraocular retinoblastoma: initial results Ophthalmology 115 2008 1398 1404
17. C.L. Shields, C.G. Bianciotto, and P. Jabbour et al. Intra-arterial chemotherapy for retinoblastoma: report no. 1, control of retinal tumors, subretinal seeds, and vitreous seeds Arch Ophthalmol 129 2011 1399 1406
18. C.L. Shields, C.G. Bianciotto, and P. Jabbour et al. Intra-arterial chemotherapy for retinoblastoma: report no. 2, treatment complications Arch Ophthalmol 129 2011 1407 1415
19. M.W. Wilson, B.G. Haik, and M.A. Dyer Superselective intraophthalmic artery chemotherapy: what we do not know Arch Ophthalmol 129 2011 1490 1491
20. D.H. Abramson, B.P. Marr, and I.J. Dunkel et al. Intra-arterial chemotherapy for retinoblastoma in eyes with vitreous and/or subretinal seeding: 2-year results Br J Ophthalmol 96 2012 499 502
21. R.C. Eagle Jr., C.L. Shields, and C. Bianciotto et al. Histopathologic observations after intra-arterial chemotherapy for retinoblastoma Arch Ophthalmol 129 2011 1416 1421
22. S. Seregard, E. Kock, and E. Trampe Intravitreal chemotherapy for recurrent retinoblastoma in an only eye [letter] Br J Ophthalmol 79 1995 194 195
23. S. Suzuki, and A. Kaneko management of intraocular retinoblastoma and ocular prognosis Int J Clin Oncol 9 2004 1 6
24. T. Kivelä, S. Eskelin, and M. Paloheimo Intravitreal methotrexate for retinoblastoma [letter] Ophthalmology 118 2011 1689
25. F.L. Munier, M.C. Gaillard, and A. Balmer et al. Intravitreal chemotherapy for vitreous disease in retinoblastoma revisited: from prohibition to conditional indications Br J Ophthalmol 96 2012 1078 1083
26. F. Ghassemi, and C.L. Shields Intravitreal melphalan for refractory or recurrent vitreous seeding from retinoblastoma Arch Ophthalmol 130 2012 1268 1271
27. S. Seregard, and A.D. Singh Retinoblastoma: direct chemotherapeutic drug delivery into the vitreous cavity Br J Ophthalmol 96 2012 473 474
28. D.H. Abramson, C.M. Frank, and I.J. Dunkel A phase I/II study of subconjunctival carboplatin for intraocular retinoblastoma Ophthalmology 106 1999 1947 1950
29. I. Schmack, G.B. Hubbard, and S.J. Kang et al. Ischemic necrosis and atrophy of the optic nerve after periocular carboplatin injection for intraocular retinoblastoma Am J Ophthalmol 142 2006 310 315
30. A. Mulvihill, A. Budning, and V. Jay et al. Ocular motility changes after subtenons carboplatin chemotherapy for retinoblastoma Arch Ophthalmol 121 2003 1120 1124
31. A.C. Mallipatna, H. Demaras, and H.S. Chan et al. Periocular topotecan for intraocular retinoblastoma Arch Ophthalmol 129 2011 738 745
32. K.R. Van Quill, P.K. Dioguardi, and C.T. Tong et al. Subconjunctival carboplatin in fibrin sealant in the treatment of transgenic murine retinoblastoma Ophthalmology 112 2005 1151 1158
33. D. Shome, N. Poddar, and V. Sharma et al. Does a nanomolecule of carboplatin injected periocularly help in attaining higher intravitreal concentrations? Invest Ophthalmol Vis Sci 50 2009 5896 5900
34. C.L. Shields, A. Ramasubramanian, and A. Thangappan et al. Chemoreduction for group E retinoblastoma: comparison of chemoreduction alone versus chemoreduction plus low-dose external radiotherapy in 76 eyes Ophthalmology 116 2009 544 551
35. C.L. Shields, A. Mashayekhi, and A.K. Au et al. The International Classification of Retinoblastoma predicts chemoreduction success Ophthalmology 113 2006 2276 2280
36. K. Gunduz, I. Gunalp, and N. Yalcindag et al. Causes of chemoreduction failure in retinoblastoma and analysis of associated factors leading to eventual treatment with external beam radiotherapy and enucleation Ophthalmology 111 2004 1917 1924
37. G.L. Chantada Retinoblastoma: lessons and challenges from developing countries. Ellsworth Lecture 2011 Ophthalmic Genet 32 2011 196 203
38. T.W. Wilson, H.S. Chan, and G.M. Moselhy et al. Penetration of chemotherapy into vitreous is increased by cryotherapy and cyclosporine in rabbits Arch Ophthalmol 114 1996 1390 1395
39. A.T. Meadows, M. Chintagumpala, and I.J. Dunkel et al. Children's Oncology Group (COG) trials for retinoblastoma A.D. Singh, B.E. Damato, J. Pe'er, Clinical Ophthalmic Oncology 2007 Saunders-Elsevier Philadelphia, PA 491 495
40. V.A. Reddy, S.G. Honavar, and D. Shome et al. Demographics, clinical profile, management and outcome of retinoblastoma J Clin Oncol 26 Suppl 2008 Abstr 10051